For decades, the pharmaceutical industry and its enablers in the FDA, CDC, and mainstream medicine have systematically suppressed the truth about DMSO (dimethyl sulfoxide)—a powerful natural compound extracted from trees that holds the key to tissue regeneration, cancer remission, inflammation reversal, and chronic pain relief.

DMSO is one of the most well-researched yet censored substances in modern medicine, with over 11,000 scientific studies documenting its therapeutic potential since the 1960s. Yet Big Pharma buried it under a mountain of false “safety concerns” because it cannot be patented and threatens the profitability of toxic chemotherapy, opioids, and synthetic pharmaceuticals.

A 2014 study in Cancer Letters found that DMSO combined with hematoxylin (a plant dye) induced complete remission in cervical cancer patients by triggering apoptosis. This research was suppressed due to its potential to undermine the chemo-radiation industry.

DMSO’s unique properties as a polar solvent allow it to dissolve and transport both water-soluble and fat-soluble compounds deep into tissues. Veterinarians and sports doctors have used DMSO for decades to treat racehorses, athletes, and chronic pain without adverse effects. However, the FDA restricts its use in humans while approving toxic opioids.

The compound also reactivates the body’s regenerative potential—similar to how lizards regrow severed tails and human livers regenerate. By stimulating stem cells and neuroplasticity, DMSO may unlock the body’s innate healing abilities. Despite decades of research, the FDA continues to censor DMSO for human use while approving treatments that bankrupt patients. This pattern reveals a systemic prioritization of pharmaceutical profits over patient health.